WASHINGTON (Reuters) - Researchers dedicated to finding a gel or cream that could work invisibly to protect women from AIDS the way a condom does said on Wednesday they got permission from Pfizer Inc. to use its newest HIV drug. The International Partnership for Microbicides said Pfizer gave it a royalty-free license to try to develop maraviroc in a cream or gel for the prevention of HIV infection.
